Funding for this research was provided by:
Text and Data Mining valid from 2018-05-02
Received: 16 August 2017
Accepted: 20 April 2018
First Online: 2 May 2018
Ethics approval and consent to participate
: The CHESS study was reviewed by the Research Ethics Sub Committee of the Faculty of Health and Social Care within the University of Chester. Patient consent for use of clinical data was not required (as per European Pharmaceutical Market Research Association (EPhMRA) guidelines). Patient consent was obtained via tick box selection for the PSC element of the study.
: LW and CH are employees of Novo Nordisk.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.